Ut Bene Pharma Private Limited
About Ut Bene Pharma Private Limited
Data last updated:
Ut Bene Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2011PTC213482. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jagdish Harsh and Deepti Sahni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 115 2nd Floor Okhla Industrial Area Phase – 1, New, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹15,000. For the same year it recorded a net profit of ₹7,920 (net margin 52.8%) and EBITDA of ₹7,920 (EBITDA margin 52.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 115 2nd Floor Okhla Industrial Area Phase – 1, New, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ut Bene Pharma Private Limited FY 2025 filings available
Ut Bene Pharma Private Limited reported revenue of ₹15,000 for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ut Bene Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ut Bene Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7,920 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7,920 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ut Bene Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 52.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 52.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ut Bene Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ut Bene Pharma Private Limited
Ut Bene Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trugrace Pharmaceuticals Private Limited | ₹15,009 (FY 2025) | •••• | •••• | •••• | Kadi, Gujarat, India | |
| Ut Bene Pharma Private Limited this company | ₹15,000 (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| VRX World Pharmacy Private Limited | ₹15,000 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| New India Chemical Pharmaceutical Works Private Limited | ₹15,000 (FY 2025) | •••• | •••• | •••• | Uttar Pradesh, Uttarakhand, India | |
| Jyostna Laboratories Private Limited | ₹15,000 (FY 2024) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| Avant Garde Medchem Private Limited | ₹15,000 (FY 2024) | •••• | •••• | •••• | Hyd, Telangana, India | |
| Yatnam Lab Limited | ₹15,000 (FY 2025) | •••• | •••• | -99.0% | •••• | Balanagar, Telangana, India |
| VXL Natural Health and Hygiene Private Limited | ₹15,000 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Beaconpath Foundation | ₹14,791 (FY 2021) | •••• | •••• | -90.0% | •••• | New Delhi, Delhi, India |
| Zenith Formulations Private Limited | ₹14,672 (FY 2025) | •••• | •••• | •••• | Ahmadabad City, Gujarat, India | |
| Jagdamba Global Chemtech Private Limited | ₹14,064 (FY 2023) | •••• | •••• | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Ut Bene Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ut Bene Pharma Private Limited
Ut Bene Pharma Private Limited is audited by ALOK SINHAL & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ALOK SINHAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ut Bene Pharma Private Limited
Ut Bene Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdish Harsh Also directs: Trikon Networks Private Limited, Mobiloitte Technologies India Private Limited, Mobiloitte Foundation and 1 more | Director | 07 Feb 2011 | 15 Years 8 Months | Current |
| Deepti Sahni Also directs: Mobiloitte Technologies India Private Limited, Mobiloitte Foundation, Enlaces & Listas Health Private Limited and 2 more | Director | 07 Feb 2011 | 15 Years 8 Months | Current |
Ownership and Shareholding of Ut Bene Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ut Bene Pharma Private Limited
Ut Bene Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ut Bene Pharma Private Limited
Employment history and EPFO contributions of people linked to Ut Bene Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ut Bene Pharma Private Limited
Ut Bene Pharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Deepti Sahni was appointed as Director on 07 Feb 2011.
Credit Ratings, Litigation & Regulatory Alerts for Ut Bene Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ut Bene Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ut Bene Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ut Bene Pharma Private Limited
Ut Bene Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ut Bene Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ut Bene Pharma Private Limited
Ut Bene Pharma is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 February 2011 (15+ years old) and is registered under CIN U74900DL2011PTC213482.
Ut Bene Pharma reported revenue of ₹15,000 for FY 2025.
Ut Bene Pharma has 2 current directors:
- Jagdish Harsh - Director
- Deepti Sahni - Director
Ut Bene Pharma reported a net profit of ₹7,920 (net margin 52.8%) and EBITDA of ₹7,920 (EBITDA margin 52.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ut Bene Pharma is -9% over three years and -7% over five years. CAGR is the steady yearly rate that links the first and the last year.
No. Ut Bene Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ut Bene Pharma is U74900DL2011PTC213482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ut Bene Pharma was incorporated on 07 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ut Bene Pharma by revenue are Trugrace Pharmaceuticals Private Limited, VRX World Pharmacy Private Limited, New India Chemical Pharmaceutical Works Private Limited, Jyostna Laboratories Private Limited, Avant Garde Medchem Private Limited and 5 more, all in the Pharma industry (Formulations).
Deepti Sahni was appointed as Director on 07 Feb 2011. Jagdish Harsh was appointed as Director on 07 Feb 2011.
The registered office of Ut Bene Pharma is at D – 115 2nd Floor Okhla Industrial Area Phase – 1, New, Delhi, India – 110020.